BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28383667)

  • 21. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
    Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
    Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells.
    Du L; Anderson A; Nguyen K; Ojeda SS; Ortiz-Rivera I; Nguyen TN; Zhang T; Kaoud TS; Gray NS; Dalby KN; Tsai KY
    ACS Chem Biol; 2019 Jul; 14(7):1426-1435. PubMed ID: 31063355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midkine is up-regulated in both cancerous and inflamed bowel, reflecting lymph node metastasis in colorectal cancer and clinical activity of ulcerative colitis.
    Krzystek-Korpacka M; Gorska S; Diakowska D; Kapturkiewicz B; Podkowik M; Gamian A; Bednarz-Misa I
    Cytokine; 2017 Jan; 89():68-75. PubMed ID: 27692729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nondysplastic Ulcerative Colitis Has High Levels of the Homologous Recombination Repair Protein NUCKS1 and Low Levels of the DNA Damage Marker Gamma-H2AX.
    De Angelis PM; Schjølberg AR; Hughes JB; Huitfeldt HS; Norheim Andersen S; Østvold AC
    Inflamm Bowel Dis; 2018 Feb; 24(3):593-600. PubMed ID: 29462394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
    He Y; Chen L; Chen K; Sun Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Inflammation in the Development of Colorectal Cancer.
    Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
    Yu LZ; Wang HY; Yang SP; Yuan ZP; Xu FY; Sun C; Shi RH
    World J Gastroenterol; 2013 May; 19(17):2638-49. PubMed ID: 23674871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased claudin-1 protein expression contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer.
    Kinugasa T; Akagi Y; Yoshida T; Ryu Y; Shiratuchi I; Ishibashi N; Shirouzu K
    Anticancer Res; 2010 Aug; 30(8):3181-6. PubMed ID: 20871038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice.
    Chromik AM; Müller AM; Körner J; Belyaev O; Holland-Letz T; Schmitz F; Herdegen T; Uhl W; Mittelkötter U
    J Invest Surg; 2007; 20(1):23-33. PubMed ID: 17365404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-apoptotic function of caspases in a cellular model of hydrogen peroxide-associated colitis.
    Poehlmann A; Reissig K; Just A; Walluscheck D; Hartig R; Schinlauer A; Lessel W; Guenther T; Silver A; Steinberg P; Roessner A
    J Cell Mol Med; 2013 Jul; 17(7):901-13. PubMed ID: 23742011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
    Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
    Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma.
    Aust DE; Haase M; Dobryden L; Markwarth A; Löhrs U; Wittekind C; Baretton GB; Tannapfel A
    Int J Cancer; 2005 Jul; 115(5):673-7. PubMed ID: 15704157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
    Lin MX; Wen ZF; Feng ZY; He D
    Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer.
    Sui H; Cai GX; Pan SF; Deng WL; Wang YW; Chen ZS; Cai SJ; Zhu HR; Li Q
    Mol Cancer Ther; 2014 Dec; 13(12):3137-51. PubMed ID: 25205654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.